Close Menu

NEW YORK – Natera on Tuesday filed a countersuit against CareDx, accusing the molecular diagnostics company of false advertising, "tortious interference with Natera's prospective economic advantage," unfair competition, and violations of the Delaware Uniform Deceptive Trade Practices Act.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.